Home › Diabete di tipo 2 › Ohio › Cincinnati
Studi clinici su Diabete di tipo 2 a Cincinnati, OH
12 studi su Diabete di tipo 2 cercano partecipanti presso sedi a Cincinnati e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
In reclutamentoFase 3
- The Christ Hospital, Cincinnati
- Velocity Clinical Research-Cincinnati-69044, Cincinnati
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
In reclutamentoFase 2
- Velocity Clinical Research, Cincinnati, Springdale, Cincinnati
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
In reclutamentoVolontari sani benvenuti
- St Elizabeth Health Care - CRI, Edgewood · a 8 mi di distanza
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
In reclutamentoFase 3
- Midwest Eye Center, Cincinnati
- Velocity Clinical Research, Mt. Auburn, Cincinnati
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
In reclutamentoFase 3
- AURORA-2 Clinical Site, Cincinnati
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
In reclutamentoFase 2
- Velocity Clinical Research, Cincinnati, Mt. Auburn, Cincinnati
- Velocity Clinical Research - Cincinnati, Blue Ash, Cincinnati
- St. Elizabeth Healthcare, Edgewood · a 8 mi di distanza
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
In reclutamentoFase 3
- Velocity Clinical Research - Cincinnati, Cincinnati
- Velocity Clinical Research - Springdale, Cincinnati
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
In reclutamentoFase 3
- Research Site, Cincinnati
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
In reclutamentoFase 3
- Univ of Cincinnati Med Cent, Cincinnati
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
In reclutamentoFase 3
- Childrens Hospital Medical Center, Cincinnati
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
In reclutamentoStudio osservazionale
- Cincinnati Children's Hospital, Cincinnati
Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY)
In reclutamentoFase 2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Studi su Diabete di tipo 2 in altre città
- San Antonio, TX37 studi
- Houston, TX31 studi
- Orlando, FL24 studi
- Boston, MA20 studi
- Miami, FL19 studi
- Dallas, TX19 studi
- Chicago, IL19 studi
- Columbus, OH18 studi
- Las Vegas, NV18 studi
- San Diego, CA17 studi
- Atlanta, GA17 studi
- New York City, NY16 studi
Altri studi a Cincinnati
- Cancro del polmone non a piccole cellule35 studi
- Cancro (tutti i tipi)27 studi
- Cancro al seno25 studi
- Insufficienza cardiaca24 studi
- Cancro colorettale21 studi
- Cancro metastatico20 studi
- Leucemia mieloide acuta20 studi
- Cancro ai polmoni19 studi
- Cancro ovarico19 studi
- Obesità19 studi
- Cancro alla prostata18 studi
- Mieloma multiplo17 studi
Fonte: ClinicalTrials.gov, dati recuperati il 2 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.